The interaction between ZDHHC9 and PD-L1 is affirmed, knockdown of ZDHHC9 in cancer cells induces a significant reduction of PD-L1 palmitoylation and sensitizes T-cell-mediated killing, hence inhibiting tumor growth. Here, ZDHHC9 is linked to neoplasm.